Meitav Investment House’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-449,302
Closed -$46.5M 317
2023
Q4
$46.5M Buy
449,302
+39,954
+10% +$4.13M 0.68% 44
2023
Q3
$37.7M Buy
409,348
+361,530
+756% +$33.3M 0.61% 52
2023
Q2
$3.75M Sell
47,818
-8,100
-14% -$635K 0.06% 142
2023
Q1
$4.49M Sell
55,918
-10,180
-15% -$818K 0.08% 144
2022
Q4
$4.46M Sell
66,098
-34,500
-34% -$2.33M 0.08% 150
2022
Q3
$5.04M Sell
100,598
-760
-0.7% -$38K 0.09% 142
2022
Q2
$5.63M Sell
101,358
-5,006
-5% -$278K 0.1% 137
2022
Q1
$5.95M Sell
106,364
-35,324
-25% -$1.98M 0.09% 151
2021
Q4
$7.9M Sell
141,688
-2,654
-2% -$148K 0.13% 132
2021
Q3
$6.93M Buy
144,342
+57,854
+67% +$2.78M 0.11% 140
2021
Q2
$3.62M Buy
86,488
+18,468
+27% +$774K 0.09% 143
2021
Q1
$2.4K Buy
68,020
+23,500
+53% +$828 0.07% 151
2020
Q4
$1.56M Hold
44,520
0.06% 139
2020
Q3
$1.55M Hold
44,520
0.08% 125
2020
Q2
$1.46M Buy
+44,520
New +$1.46M 0.09% 118